No definition available.
Congenital malformations of spine and bony thorax
DOID EFO Endpoint Browser PheWeb
Q17_CONGEN_MALFO_SPINE_BONY_THORAX
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
217 |
4. Check minimum number of eventsNone |
217 |
5. Include endpointsNone |
217 |
6. Filter based on genotype QC (FinnGen only) |
217 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_DEFORMAT_MUSCULOS_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q6[5-9]|Q7
- Name in latin
- Malformationes congenitae columnae vertebralis et ossium thoracis
Similar endpoints
↥List of similar endpoints to
Congenital malformations of spine and bony thorax
based on the number of shared cases.
Similar with more cases:
- Congenital malformations and deformations of the musculoskeletal system
- Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2337 | 1195 | 1137 |
| Only index persons | 2038 | 1078 | 960 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.03 |
| Only index persons | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 14.46 | 15.32 | 13.42 |
| Only index persons | 15.67 | 16.60 | 14.63 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 217 | 139 | 78 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.03 |
| Median age at first event (years) | 25.96 | 30.86 | 17.24 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 190
- Matched controls
- 1899
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q76.30
ICD-10 Finland
Hemivertebra fusion or failure of segmentation with scoliosis
+∞
53.7
49
*
Q76.48
ICD-10 Finland
Congenital anomalies of other vertebrae, not associated with scoliosis
+∞
38.9
36
*
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
29.5
31.3
42
18
Q76.1
ICD-10 Finland
Klippel-Feil syndrome
+∞
27.8
26
*
Q76.38
ICD-10 Finland
Congenital scoliosis due to other specified congenital bony malformation
+∞
26.7
25
*
Q76.9
ICD-10 Finland
Congenital malformation of bony thorax, unspecified
+∞
20.2
19
*
Q76.3
ICD-10 Finland
Congenital scoliosis due to congenital bony malformation
+∞
16.9
16
*
N06AX21
ATC
duloxetine; oral
6.9
16.8
44
79
N03AX12
ATC
gabapentin; oral
5.9
16.0
48
103
M41.1
ICD-10 Finland
Juvenile idiopathic scoliosis
21.3
14.6
21
11
N02AX02
ATC
tramadol; systemic, rectal
3.6
14.0
84
345
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
+∞
13.7
13
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
7.1
12.5
31
51
N03AX16
ATC
pregabalin; oral
4.0
11.9
53
168
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
69.4
11.8
13
*
M41.9
ICD-10 Finland
Scoliosis, unspecified
16.8
11.1
17
11
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
8.2
10.9
24
33
ZXE20
NOMESCO Finland
More than three and less than five hours
4.3
10.8
42
117
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
9.7
10.6
21
24
Q76.0
ICD-10 Finland
Spina bifida occulta
+∞
10.5
10
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
10.4
76
347
M79.0
ICD-10 Finland
Rheumatism, unspecified
13.2
10.1
17
14
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.0
9.8
42
127
UKC02
NOMESCO Finland
Cystoscopy
5.3
9.8
30
65
Q87.26
ICD-10 Finland
VATER association
+∞
9.4
9
*
Q76.5
ICD-10 Finland
Cervical rib
+∞
9.4
9
*
Q76.68
ICD-10 Finland
Other congenital malformations of ribs
+∞
9.4
9
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
5.0
8.7
28
64
Z31.5
ICD-10 Finland
Genetic counselling
4.8
8.7
29
69
XKC03
NOMESCO Finland
Water cystometry
17.3
8.7
13
8
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
13.6
8.5
14
11
ZXD10
NOMESCO Finland
Scheduled procedure
2.5
8.4
91
508
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.3
8.4
31
82
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.3
8.3
45
164
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.3
8.3
31
83
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.3
8.2
44
158
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.8
8.1
35
107
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
8.1
81
431
N06AA09
ATC
amitriptyline; systemic
5.1
8.1
25
55
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.5
8.0
23
46
TPH07
NOMESCO Finland
Cathetrisation of artery
4.2
7.9
30
81
M54.2
ICD-10 Finland
Cervicalgia
5.1
7.8
24
52
ZXD05
NOMESCO Finland
Urgent procedure
2.5
7.7
72
368
Z3226
NOMESCO Finland
Physiotherapist
2.8
7.7
57
254
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.1
7.6
43
162
R4110
NOMESCO Finland
Physiotherapy
2.6
7.5
65
316
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
7.4
79
427
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.8
7.4
24
56
Q76.2
ICD-10 Finland
Congenital spondylolisthesis
+∞
7.3
7
*
Q76.42
ICD-10 Finland
Congenital anomalies of sacral vetebrae
+∞
7.3
7
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
16.6
7.3
11
7
N03AE01
ATC
clonazepam; systemic
6.1
7.3
19
34
M54.5
ICD-10 Finland
Low back pain
2.5
7.3
68
345
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
8.0
7.0
15
20
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.1
7.0
21
45
J45.9
ICD-10 Finland
Asthma, unspecified
3.0
6.9
43
171
Z01.8
ICD-10 Finland
Other specified special examinations
2.8
6.9
48
204
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
17.5
6.8
10
6
M41.5
ICD-10 Finland
Other secondary scoliosis
41.6
6.8
8
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
6.9
6.8
16
25
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.4
6.8
24
61
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
23.5
6.7
9
*
Q25.0
ICD-10 Finland
Patent ductus arteriosus
15.0
6.5
10
7
ZXA05
NOMESCO Finland
Left side
2.7
6.4
48
212
M35.7
ICD-10 Finland
Hypermobility syndrome
9.8
6.4
12
13
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
6.4
55
265
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
18.8
6.3
9
5
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
18.8
6.3
9
5
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.1
6.3
16
28
Q76.40
ICD-10 Finland
Congenital absence of vertebrae without scoliosis
+∞
6.3
6
*
Q66.0
ICD-10 Finland
Talipes equinovarus
+∞
6.3
6
*
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
+∞
6.3
6
*
M23.5
ICD-10 Finland
Chronic instability of knee
+∞
6.3
6
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
8.1
6.2
13
17
M54.6
ICD-10 Finland
Pain in thoracic spine
4.4
6.1
21
52
J45.8
ICD-10 Finland
Mixed asthma
7.7
6.0
13
18
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
6.0
46
206
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
70
384
2.21
6.52
2.8
2.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
45
205
2.51
6.38
3.3
2.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
31
120
2.85
6.03
11.2
14.1
%
97.1
95.8
0.82
31
114
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
33
136
2.68
5.71
10.8
12.6
kpa
5.5
5.3
0.65
33
130
(3027801) Oxygen [Partial pressure] in Arterial blood
33
136
2.68
5.71
10.8
12.6
kpa
15.4
13.9
0.48
33
130
(3044640) Blood type and Crossmatch panel - Blood
82
509
1.98
5.34
3.1
2.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
66
3.24
5.09
13.5
18.3
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
27
107
2.74
5.02
12.0
13.1
g/l
120.5
122.9
0.25
27
102
(3000991) Gas panel - Venous blood
39
185
2.35
5.02
15.8
10.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
103
2.73
4.84
2.0
1.5
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
19
63
3.21
4.80
7.1
7.7
%
137.1
183.9
2.17
19
63
(3011397) Hemoglobin [Presence] in Urine by Test strip
63
370
1.99
4.72
4.8
3.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
37
178
2.30
4.61
2.8
2.5
%
20.1
23.8
0.73
31
154
(3023520) Reticulocytes [#/volume] in Blood
27
112
2.61
4.60
1.7
4.1
e9/l
69.6
65.9
0.21
21
85
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
43
226
2.13
4.31
1.6
1.5
pmol/l
148837639.7
474.7
0.49
43
196
(3013115) Eosinophils [#/volume] in Blood
129
973
1.80
4.28
9.8
7.7
e9/l
0.2
0.2
1.48
121
869
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
23
4.51
4.13
1.7
4.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
93
645
1.77
4.04
8.0
7.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
58
351
1.89
3.91
3.4
2.8
mg/l
1.0
0.8
0.38
45
262
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
7
8
8.99
3.80
2.7
2.4
%
88.4
124.1
—
7
8
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
103
746
1.72
3.78
14.9
8.7
mmol/l
1.2
1.2
0.74
98
646
(3019060) Gas panel - Arterial blood
19
73
2.76
3.75
13.8
10.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
54
327
1.87
3.61
5.8
4.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
41
3.31
3.56
2.8
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
32
162
2.14
3.52
11.2
5.9
mmol/l
2.2
1.4
0.76
27
121
(3044290) Cell count panel - Cerebral spinal fluid
12
37
3.37
3.39
1.2
4.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
38
209
1.99
3.36
14.6
7.8
mmol/l
1.8
1.5
0.25
32
161
(3026782) Osmolality of Urine
53
328
1.81
3.29
4.8
2.8
mosm/kgh2o
517.8
569.1
0.87
46
277
(3019309) Folate [Moles/volume] in Red Blood Cells
36
196
2.00
3.27
1.5
1.6
nmol/l
1166.4
1161.4
0.01
30
149
(3032080) INR in Blood by Coagulation assay
72
488
1.71
3.27
5.8
5.9
inr
1.0
1.2
4.30
19
146
(3009214) Lutropin [Units/volume] in Serum or Plasma
23
107
2.29
3.09
1.4
2.0
u/l
8.1
9.2
0.17
18
82
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
146
1200
1.66
3.05
9.2
6.7
u/l
85.1
87.7
0.24
138
1119
(3021601) Nitrite [Presence] in Urine by Test strip
107
815
1.62
3.04
5.4
4.8
estimate
0.0
0.0
0.00
18
162
(1761868) Lipid panel - Serum or Plasma
37
597
0.54
2.93
2.0
2.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
100
755
1.60
2.91
4.4
4.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
131
1056
1.61
2.89
10.5
10.2
e9/l
4.1
3.9
0.34
125
925
(3009261) Glucose [Presence] in Urine by Test strip
107
824
1.59
2.85
4.1
3.4
estimate
0.0
0.0
0.00
18
156
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
36
3.17
2.85
2.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
36
3.17
2.85
2.3
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
106
815
1.59
2.84
4.2
3.4
estimate
0.0
0.0
0.00
18
159
(3015377) Calcium [Moles/volume] in Serum or Plasma
71
496
1.64
2.82
2.9
2.9
mmol/l
2.4
2.4
0.35
62
446
(1616796) Gas panel - Central venous blood
10
31
3.33
2.81
2.2
5.5
—
—
—
0
0
(4062490)
9
23
4.04
2.80
1.3
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
29
156
1.99
2.73
2.2
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
60
408
1.65
2.63
3.4
2.7
mg/l
3.3
2.8
0.76
52
354
(3000850) Epithelial cells [#/volume] in Urine
53
350
1.68
2.59
4.8
2.8
e6/l
6.7
5.3
0.29
47
304
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
17
75
2.37
2.58
3.1
1.3
—
—
—
0
0
(3015736) pH of Urine
87
650
1.56
2.58
4.0
3.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
29
160
1.94
2.55
2.2
1.6
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
13
51
2.65
2.49
17.6
13.5
%
2.1
1.6
0.82
13
46
(3052851) Hemolysis interference index of Serum or Plasma
13
51
2.65
2.49
3.5
2.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
76
554
1.57
2.49
7.7
3.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
21
3.91
2.49
1.3
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
141
1180
1.56
2.46
6.2
4.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
186
0.36
2.42
1.6
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
26
141
1.96
2.40
12.0
5.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
22
3.73
2.39
1.3
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
8
6.36
2.38
1.6
1.0
%
90.6
83.9
—
5
8
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
8
6.36
2.38
1.4
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
21
106
2.09
2.35
5.4
3.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
32
188
1.82
2.33
3.1
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
61
428
1.59
2.33
4.6
3.6
estimate
0.0
0.0
0.50
16
160
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
13
4.71
2.28
1.5
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
65
467
1.56
2.24
4.4
2.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
15
67
2.33
2.23
2.3
1.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
5
9
5.65
2.22
3.2
2.3
u/ml
406.6
1151.0
—
5
9
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
69
504
1.54
2.21
2.2
1.8
pmol/l
90.7
94.3
0.26
42
252
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
38
242
1.69
2.11
4.0
3.2
ng/l
1721.3
373.8
0.95
23
139
(3013826) Glucose [Moles/volume] in Serum or Plasma
116
951
1.47
2.09
10.6
5.8
mmol/l
6.4
6.5
0.04
110
852
(3018095) Leukocytes [#/volume] in Urine
78
591
1.50
2.09
7.5
4.1
e6/l
44.8
38.1
0.13
58
412
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
10
5.09
2.08
1.0
1.0
miu/ml
880.4
1654.5
—
5
10
(36304419) Bacteria [Presence] in Urine
63
457
1.53
2.06
7.2
3.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
22
119
1.94
2.06
7.3
5.6
ng/l
47.9
61.2
0.88
22
111
(3021901) Oxygen saturation in Capillary blood
8
26
3.15
2.03
2.5
3.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
46
316
1.58
1.90
2.6
2.9
ug/g
150.7
112.9
0.20
30
234
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
95
760
1.44
1.89
5.4
6.8
umol/l
11.0
10.4
0.15
90
715
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
35
225
1.66
1.88
2.2
1.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
11
46
2.47
1.88
1.4
3.7
e6/l
198.1
372.2
0.35
11
36
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
11
46
2.47
1.88
1.2
3.6
e6/l
1.2
3.2
1.30
11
35
(3030467) Casts [#/volume] in Urine by Automated count
62
457
1.50
1.87
7.2
3.4
e6/l
0.5
0.2
0.27
52
346
(40761511) CBC panel - Blood by Automated count
201
1878
1.95
1.84
16.9
9.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
28
172
1.72
1.78
1.6
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
42
288
1.57
1.75
1.2
1.2
u/ml
5.2
6.8
0.13
21
105
(3024928) Oxygen saturation in Venous blood
8
30
2.73
1.74
46.4
12.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
40
274
1.56
1.68
5.8
3.0
e6/l
2.4
0.7
0.99
29
165
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
19
3.22
1.67
1.0
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
144
1261
1.42
1.65
4.7
4.3
mm/h
8.4
9.1
0.41
138
1168
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
22
129
1.79
1.64
2.2
2.3
—
18.2
—
0
6
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
14
3.63
1.62
1.4
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
14
3.63
1.62
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
53
389
1.48
1.62
4.5
3.1
kg/l
1.0
1.0
—
8
59
(3014051) Protein [Presence] in Urine by Test strip
8
32
2.56
1.61
2.6
1.6
—
—
—
0
0
(3020891) Body temperature
11
50
2.26
1.60
8.4
4.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
78
620
1.40
1.55
4.1
3.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
38
262
1.55
1.55
6.0
3.2
e6/l
3.1
2.6
0.21
27
154
(3009508) Creatinine [Moles/volume] in Urine
59
446
1.44
1.55
4.5
3.5
mmol/l
7.4
8.5
0.96
54
398
(3017446) Testosterone [Moles/volume] in Serum or Plasma
21
124
1.77
1.54
1.7
2.2
nmol/l
10.0
12.2
0.53
16
109
(4306422)
7
27
2.64
1.53
1.4
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
104
870
1.38
1.52
10.0
9.5
e9/l
0.0
0.0
0.49
94
694
(40758558) Short blood count panel - Blood
62
479
1.41
1.44
7.7
8.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
10
46
2.23
1.42
1.2
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
9
40
2.30
1.42
23.6
16.5
mmol/l
1.1
1.2
—
9
35
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
41
2.25
1.38
1.3
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
14
75
1.93
1.38
4.6
1.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
23
2.65
1.37
3.5
2.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
17
2.98
1.36
1.4
1.1
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
39
0.00
1.35
0.0
1.1
—
2.6
—
0
6
(3044889) 12 lead EKG panel
115
990
1.34
1.35
3.5
3.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
41
297
1.47
1.34
1.3
1.3
iu/ml
37.7
32.0
0.11
11
80
(3022145) Colonoscopy Study observation
25
162
1.61
1.33
1.5
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
135
0.43
1.32
1.5
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
192
1801
1.57
1.32
19.6
11.5
mg/l
23.0
20.9
0.40
163
1319
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
60
468
1.39
1.31
4.2
3.2
ng/l
22.9
31.6
0.34
36
243
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
18
2.82
1.29
1.2
7.7
%
93.4
97.3
—
5
18
(3002582) Erythrocytes [#/volume] in Urine
63
497
1.38
1.29
7.2
3.5
e6/l
24.7
40.5
0.60
53
385
(3022621) pH of Urine by Test strip
16
92
1.80
1.29
2.5
1.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
70
1.91
1.27
2.2
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
20
2.53
1.15
1.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
36
0.00
1.15
0.0
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
34
245
1.46
1.15
1.5
1.6
titre
400.0
550.2
—
8
49
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
22
144
1.59
1.14
3.7
6.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
36
267
1.42
1.05
1.7
1.9
%
1.7
1.4
1.05
31
239
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
34
2.09
1.04
1.3
2.9
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
34
2.09
1.04
6.1
4.3
%
61.3
54.3
—
7
34
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
34
2.09
1.04
6.1
4.1
e9/l
3.5
3.8
—
7
34
(3019225) pH of Specimen
18
115
1.62
1.03
4.0
4.6
—
—
—
0
0
(4034850)
9
48
1.91
1.02
7.1
7.3
—
—
—
0
0
(3018418) pH of Serum or Plasma
52
414
1.34
1.00
5.4
3.8
ph
7.4
7.4
—
5
74
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
29
0.00
0.98
0.0
2.9
—
15.4
—
0
15
(3035637) Corticotropin [Mass/volume] in Plasma
10
54
1.89
0.98
2.2
1.6
—
—
—
0
0
(3013512) EKG study
44
343
1.35
0.97
4.4
3.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
53
426
1.32
0.95
6.1
4.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
15
94
1.64
0.93
1.9
2.7
g/l
66.2
66.3
0.02
15
89
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
15
94
1.64
0.93
1.7
2.9
ml/min/173m2
87.0
74.3
—
7
43
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
104
0.47
0.91
1.6
2.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
14
87
1.65
0.90
30.6
7.4
g/l
131.2
131.6
0.02
14
87
(3015235) Bicarbonate [Moles/volume] in Capillary blood
8
44
1.85
0.87
4.0
5.0
mmol/l
26.3
24.7
—
8
38
(3020682) Albumin/Creatinine [Ratio] in Urine
42
332
1.33
0.85
3.9
4.0
mg/mmol
5.2
12.2
1.13
29
229
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
31
1.96
0.85
1.5
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
31
1.96
0.85
1.2
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
23
165
1.44
0.82
1.3
1.3
iu/ml
36.8
149.3
—
6
65
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
47
1.73
0.81
1.3
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
6
34
1.79
0.77
6.3
3.5
mmol/l
3.7
3.8
—
6
28
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
6.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
24
2.11
0.75
1.6
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
110
0.53
0.74
1.3
1.6
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
11
68
1.65
0.73
6.3
3.8
%
48.7
51.9
0.18
11
68
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
191
1833
1.35
0.70
11.8
9.3
u/l
25.1
26.0
0.36
191
1763
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
153
1431
1.23
0.70
12.9
9.6
ml/min/173m2
97.3
92.5
1.96
134
1115
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
42
1.69
0.69
1.3
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
16
224
0.69
0.68
1.4
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
16
111
1.48
0.68
2.1
1.8
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
5
28
1.80
0.66
1.2
1.7
mosm/kgh2o
283.6
286.5
—
5
17
(3007164) IgA [Mass/volume] in Serum or Plasma
62
535
1.22
0.63
1.7
1.5
g/l
1.7
2.0
1.29
43
295
(3000330) Specific gravity of Urine by Test strip
10
63
1.62
0.63
3.1
2.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
151
0.65
0.62
1.3
1.5
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
5
30
1.68
0.62
1.0
2.4
g/l
0.0
0.0
—
5
30
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
5
30
1.68
0.62
1.0
2.4
g/l
0.0
0.0
—
5
30
(3023420) DNA double strand Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
20
149
1.38
0.60
2.4
2.6
u/l
7259.5
3694.6
0.21
13
61
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
54
1.50
0.58
1.4
2.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
124
1.40
0.57
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
24
186
1.33
0.57
1.5
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
163
1549
1.21
0.56
4.0
4.0
mmol/l
2.7
2.8
1.25
157
1446
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
38
1.60
0.55
3.7
11.2
—
3715.7
—
0
7
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
134
0.66
0.53
1.6
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
39
1.55
0.53
1.5
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
9
64
1.42
0.52
1.6
2.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
64
1.42
0.52
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
64
1.42
0.52
2.1
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
38
319
1.23
0.50
3.9
3.4
mg/l
32.3
260.9
0.69
28
227
(3011288) Drugs identified in Urine by Screen method
15
110
1.39
0.50
2.2
1.8
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
47
1.51
0.48
1.3
1.5
—
—
—
0
0
(4010399)
14
103
1.38
0.46
1.2
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
16
207
0.75
0.45
1.1
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
69
1.47
0.45
2.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
130
0.68
0.44
1.4
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
15
113
1.35
0.44
4.1
3.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
160
1531
1.17
0.44
3.6
3.7
mmol/l
1.4
1.5
0.49
154
1427
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
5
31
1.63
0.43
1.0
2.3
g/l
0.0
0.0
—
5
31
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
5
32
1.58
0.42
1.0
2.3
g/l
0.0
0.2
—
5
32
(3030981) Hyaline casts [#/volume] in Urine by Automated count
10
70
1.45
0.42
1.5
3.3
e6/l
0.2
0.1
—
10
70
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
10
70
1.45
0.42
3.6
2.6
u/l
51.4
40.4
—
10
64
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
151
1576
0.86
0.42
3.5
3.8
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
17
0.00
0.41
0.0
3.8
—
100.3
—
0
17
(3007461) Platelets [#/volume] in Blood
207
2033
1.39
0.40
26.7
16.8
e9/l
263.1
259.8
0.30
207
1984
(3017143) Hepatitis C virus Ab [Presence] in Serum
34
290
1.20
0.40
1.3
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
35
1.44
0.39
1.4
2.8
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
4.1
—
55.9
—
0
19
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
37
426
0.84
0.39
2.3
2.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
66
1.38
0.39
1.2
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
9
68
1.34
0.38
1.1
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
10
72
1.41
0.37
1.0
1.1
—
12.2
—
0
10
(3024731) MCV [Entitic volume]
207
2035
1.37
0.37
26.5
16.7
fl
89.4
89.3
0.17
207
2006
(3035941) MCH [Entitic mass]
207
2035
1.37
0.37
26.6
16.7
pg
29.9
29.9
0.03
207
2005
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
156
1498
1.15
0.37
4.0
3.6
mmol/l
5.7
5.7
0.14
151
1377
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
17
211
0.79
0.36
1.9
1.8
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
41
1.48
0.36
1.2
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
207
2036
1.36
0.36
26.7
16.8
e12/l
4.5
4.6
0.09
207
1980
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
154
1480
1.14
0.35
3.4
3.4
mmol/l
1.2
1.3
0.10
149
1377
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
22
182
1.23
0.35
3.3
3.9
%
17.2
20.9
—
9
70
(3000963) Hemoglobin [Mass/volume] in Blood
207
2037
1.35
0.34
26.9
17.0
g/l
134.6
135.4
0.38
207
2009
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
6
46
1.31
0.33
2.2
1.6
nmol/l
0.3
0.3
—
6
37
(3010813) Leukocytes [#/volume] in Blood
207
2039
1.33
0.32
26.7
16.8
e9/l
6.7
6.7
0.09
207
1981
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
96
0.72
0.31
2.0
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
99
0.70
0.31
1.3
1.7
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
7
53
1.33
0.31
1.1
1.3
—
2.9
—
0
8
(3002256) Pathology report gross observation
20
166
1.23
0.31
1.5
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
7
54
1.31
0.30
1.1
1.3
—
8.6
—
0
12
(3003338) MCHC [Mass/volume]
171
1661
1.14
0.30
21.4
14.6
g/l
333.6
334.0
0.28
171
1647
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
35
395
0.86
0.30
2.3
2.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
14
112
1.27
0.29
1.3
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
65
600
1.12
0.28
1.4
1.6
u/ml
0.5
1.7
1.81
16
136
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
120
0.74
0.28
1.4
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
120
0.74
0.28
1.4
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
120
0.74
0.28
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
120
0.74
0.28
1.4
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
31
351
0.86
0.28
1.6
1.7
—
—
—
0
0
(3000492) Spirometry study
14
171
0.81
0.27
1.8
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
66
612
1.11
0.27
1.7
1.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
8
67
1.20
0.26
1.4
1.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
72
0.69
0.26
1.8
1.8
—
—
—
0
0
(1002224) Polysomnography panel
6
82
0.72
0.24
1.0
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
40
1.26
0.22
1.0
2.1
g/l
3.7
3.8
—
5
32
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
40
1.26
0.22
1.0
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
40
1.26
0.22
1.0
2.2
g/l
6.2
7.7
—
5
33
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
41
1.22
0.22
1.6
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
10
0.00
0.21
0.0
2.9
—
648.0
—
0
5
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
2.0
—
0
5
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.0
—
4.2
—
0
12
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
36
327
1.12
0.21
1.9
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
13
0.00
0.21
0.0
4.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
13
0.00
0.21
0.0
4.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.9
—
1.1
—
0
13
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
17
147
1.17
0.18
4.1
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
26
233
1.13
0.18
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
100
1.21
0.18
1.6
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
119
1.19
0.18
4.7
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
16
138
1.17
0.18
4.2
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
13
152
0.85
0.17
3.5
3.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
5
68
0.73
0.17
1.8
1.8
u/ml
257.6
168.6
—
5
38
(3027008) Opiates [Presence] in Urine
17
149
1.15
0.16
4.1
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
17
150
1.14
0.15
4.1
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
89
0.78
0.15
1.1
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
60
570
1.07
0.14
1.8
2.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
24
263
0.90
0.14
1.9
1.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
96
0.83
0.14
1.5
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
96
0.83
0.14
1.5
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
100
0.79
0.14
1.5
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
10
85
1.18
0.12
4.8
5.9
g/l
0.2
0.2
—
5
51
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
49
468
1.06
0.10
1.6
1.8
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
5
45
1.11
0.10
1.2
1.3
—
53.3
—
0
5
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
47
1.07
0.09
1.6
1.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
47
1.07
0.09
1.6
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
35
368
0.94
0.08
1.6
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
62
0.80
0.08
3.0
2.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
88
1.14
0.08
1.4
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
176
1777
0.95
0.07
20.0
12.7
%
39.4
40.1
0.67
139
1477
(3008898) HLA-B27 [Presence]
10
112
0.89
0.07
1.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
86
1.05
0.07
1.3
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
62
604
1.04
0.06
2.2
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
16
171
0.93
0.05
1.7
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
17
160
1.07
0.04
1.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
57
580
0.98
0.02
1.6
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
48
471
1.02
0.02
2.6
3.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
14
147
0.95
0.01
4.7
1.6
—
—
—
0
0
(4035726)
11
111
0.99
0.00
1.9
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
97
1.03
0.00
1.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
96
1.04
0.00
1.4
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
21
215
0.97
0.00
2.3
2.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
64
0.94
0.00
1.7
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
71
0.99
0.00
1.7
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
6
61
0.98
0.00
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
59
0.84
0.00
1.4
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
5
50
1.00
0.00
1.2
1.6
nmol/l
0.9
0.6
—
5
43
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
7
0.00
0.00
0.0
1.6
—
1770.7
—
0
7
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
5
0.00
0.00
0.0
2.4
—
129.2
—
0
5
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
57
0.87
0.00
2.6
2.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
54
0.92
0.00
3.2
2.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
99
0.91
0.00
1.3
1.2
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
4.8
—
0
6
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
7
0.00
0.00
0.0
4.7
—
52.3
—
0
7
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
53
0.94
0.00
1.4
1.1
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
67
0.89
0.00
1.5
1.7
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.7
—
1.2
—
0
7
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
6
0.00
0.00
0.0
1.0
—
17.3
—
0
6
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
0.8
—
0
7
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
9
0.00
-0.00
0.0
4.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
-0.00
0.0
2.7
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
(4211845)
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
0
9
0.00
-0.00
0.0
1.0
—
7.6
—
0
9
(21494890) Protein electrophoresis panel - 24 hour Urine
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
-0.00
0.0
2.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_SPINE_BONY_THORAX and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MALFO_SPINE_BONY_THORAX | 1.972 [1.38, 2.82] | < 0.001 |
| Birth year | 0.999 [0.99, 1.01] | 0.883 |
During the follow-up period (1.1.1998 — 31.12.2019), 54 out of 1044 females with Q17_CONGEN_MALFO_SPINE_BONY_THORAX died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_SPINE_BONY_THORAX.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.158% | No data |
| 5 | 1.134% | No data |
| 10 | 2.98% | No data |
| 15 | 6.321% | No data |
| 20 | 11.558% | No data |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_SPINE_BONY_THORAX – Congenital malformations of spine and bony thorax
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data